Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial.

Clarke, Ed; Bashorun, Adedapo; Adigweme, Ikechukwu; Badjie Hydara, Mariama; Umesi, Ama; Futa, Ahmed; Ochoge, Magnus; Obayemi, Dolapo; Edem, Bassey; Saidy-Jah, Ebrima; +12 more... Onwuchekwa, Chukwuemeka; Dhere, Rajeev; Sethna, Vistasp; Kampmann, Beate; Goldblatt, David; Taylor, Douglas; Andi-Lolo, Indah; Hosken, Nancy; Antony, Kalpana; Innis, Bruce L; Alderson, Mark R; Lamola, Steve; (2021) Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial. The Lancet. Infectious diseases. ISSN 1473-3099 DOI: https://doi.org/10.1016/S1473-3099(20)30735-0

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S1473-3099(20)30735-0

Abstract

Share

Download

Filename: PIIS1473309920307350.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar